MELK
Basic information
Region (hg38): 9:36572862-36677683
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the MELK gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 3 | |||||
missense | 34 | 41 | ||||
nonsense | 2 | |||||
start loss | 0 | |||||
frameshift | 1 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 36 | 5 | 6 |
Variants in MELK
This is a list of pathogenic ClinVar variants found in the MELK region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
9-36581731-T-C | not specified | Uncertain significance (Apr 09, 2024) | ||
9-36583645-A-C | not specified | Uncertain significance (Jan 07, 2022) | ||
9-36583645-A-G | Benign (Jun 08, 2017) | |||
9-36589541-T-G | not specified | Uncertain significance (Oct 22, 2021) | ||
9-36589580-C-G | not specified | Uncertain significance (Mar 02, 2023) | ||
9-36589615-T-G | not specified | Uncertain significance (Aug 12, 2021) | ||
9-36589639-T-A | not specified | Uncertain significance (Jun 03, 2024) | ||
9-36594656-A-G | not specified | Uncertain significance (Oct 06, 2021) | ||
9-36594660-A-G | not specified | Uncertain significance (May 17, 2023) | ||
9-36594694-C-T | not specified | Uncertain significance (Jul 19, 2023) | ||
9-36594704-T-C | not specified | Uncertain significance (May 17, 2023) | ||
9-36594732-T-C | Likely benign (Oct 10, 2018) | |||
9-36594733-G-A | not specified | Uncertain significance (Aug 28, 2023) | ||
9-36597242-A-C | not specified | Uncertain significance (Sep 27, 2022) | ||
9-36599460-C-A | not specified | Uncertain significance (Jun 07, 2023) | ||
9-36599460-C-G | not specified | Uncertain significance (Feb 21, 2024) | ||
9-36630325-G-A | Hereditary breast ovarian cancer syndrome | Uncertain significance (Aug 01, 2020) | ||
9-36630356-C-G | not specified | Uncertain significance (Oct 12, 2022) | ||
9-36633121-T-A | not specified | Uncertain significance (Dec 19, 2023) | ||
9-36633155-C-G | not specified | Uncertain significance (Dec 20, 2023) | ||
9-36633159-C-T | Likely benign (Dec 31, 2019) | |||
9-36633169-A-G | not specified | Uncertain significance (Jan 03, 2024) | ||
9-36643021-G-A | Likely benign (Apr 10, 2018) | |||
9-36643028-A-C | not specified | Uncertain significance (Jan 03, 2024) | ||
9-36643064-T-C | not specified | Uncertain significance (May 28, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
MELK | protein_coding | protein_coding | ENST00000298048 | 17 | 104820 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
4.51e-22 | 0.00250 | 125562 | 1 | 185 | 125748 | 0.000740 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.897 | 298 | 345 | 0.864 | 0.0000173 | 4264 |
Missense in Polyphen | 105 | 137.58 | 0.76319 | 1668 | ||
Synonymous | -0.349 | 124 | 119 | 1.04 | 0.00000574 | 1184 |
Loss of Function | 0.319 | 34 | 36.1 | 0.943 | 0.00000160 | 482 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000447 | 0.000439 |
Ashkenazi Jewish | 0.000100 | 0.0000992 |
East Asian | 0.00234 | 0.00223 |
Finnish | 0.0000959 | 0.0000924 |
European (Non-Finnish) | 0.000331 | 0.000308 |
Middle Eastern | 0.00234 | 0.00223 |
South Asian | 0.00325 | 0.00304 |
Other | 0.000654 | 0.000652 |
dbNSFP
Source:
- Function
- FUNCTION: Serine/threonine-protein kinase involved in various processes such as cell cycle regulation, self-renewal of stem cells, apoptosis and splicing regulation. Has a broad substrate specificity; phosphorylates BCL2L14, CDC25B, MAP3K5/ASK1 and ZNF622. Acts as an activator of apoptosis by phosphorylating and activating MAP3K5/ASK1. Acts as a regulator of cell cycle, notably by mediating phosphorylation of CDC25B, promoting localization of CDC25B to the centrosome and the spindle poles during mitosis. Plays a key role in cell proliferation and carcinogenesis. Required for proliferation of embryonic and postnatal multipotent neural progenitors. Phosphorylates and inhibits BCL2L14, possibly leading to affect mammary carcinogenesis by mediating inhibition of the pro-apoptotic function of BCL2L14. Also involved in the inhibition of spliceosome assembly during mitosis by phosphorylating ZNF622, thereby contributing to its redirection to the nucleus. May also play a role in primitive hematopoiesis. {ECO:0000269|PubMed:11802789, ECO:0000269|PubMed:12400006, ECO:0000269|PubMed:14699119, ECO:0000269|PubMed:15908796, ECO:0000269|PubMed:16216881, ECO:0000269|PubMed:17280616}.;
- Disease
- DISEASE: Note=Defects in MELK are associated with some cancers, such as brain or breast cancers. Expression is dramatically increased in aggressive undifferentiated tumors, correlating with poor patient outcome in breast and brain cancers, suggesting a role in tumor-initiating cells and proliferation via its function in cell proliferation regulation.;
Recessive Scores
- pRec
- 0.179
Intolerance Scores
- loftool
- 0.916
- rvis_EVS
- 0.62
- rvis_percentile_EVS
- 83.47
Haploinsufficiency Scores
- pHI
- 0.444
- hipred
- Y
- hipred_score
- 0.658
- ghis
- 0.551
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.746
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Melk
- Phenotype
- endocrine/exocrine gland phenotype;
Zebrafish Information Network
- Gene name
- melk
- Affected structure
- whole organism
- Phenotype tag
- abnormal
- Phenotype quality
- has fewer parts of type
Gene ontology
- Biological process
- G2/M transition of mitotic cell cycle;protein phosphorylation;apoptotic process;cell population proliferation;intrinsic apoptotic signaling pathway in response to oxidative stress;peptidyl-tyrosine phosphorylation;hemopoiesis;intracellular signal transduction;positive regulation of apoptotic process;protein autophosphorylation;neural precursor cell proliferation
- Cellular component
- nucleus;cytoplasm;plasma membrane;cell cortex;membrane
- Molecular function
- protein serine/threonine kinase activity;non-membrane spanning protein tyrosine kinase activity;calcium ion binding;protein binding;ATP binding;lipid binding